These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10194449

  • 1. Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma.
    ten Berge RL, Dukers DF, Oudejans JJ, Pulford K, Ossenkoppele GJ, de Jong D, Miseré JF, Meijer CJ.
    Blood; 1999 Apr 15; 93(8):2688-96. PubMed ID: 10194449
    [Abstract] [Full Text] [Related]

  • 2. Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker.
    ten Berge RL, Oudejans JJ, Dukers DF, Meijer JW, Ossenkoppele GJ, Meijer CJ.
    Leukemia; 2001 Mar 15; 15(3):458-64. PubMed ID: 11237071
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of activated cytotoxic T-lymphocytes in primary nodal diffuse large B-cell lymphomas.
    Muris JJ, Meijer CJ, Cillessen SA, Vos W, Kummer JA, Bladergroen BA, Bogman MJ, MacKenzie MA, Jiwa NM, Siegenbeek van Heukelom LH, Ossenkoppele GJ, Oudejans JJ.
    Leukemia; 2004 Mar 15; 18(3):589-96. PubMed ID: 14712286
    [Abstract] [Full Text] [Related]

  • 4. Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease.
    Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M.
    Blood; 1995 Sep 15; 86(6):2321-8. PubMed ID: 7662979
    [Abstract] [Full Text] [Related]

  • 5. Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.
    Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.
    Blood; 1996 Sep 01; 88(5):1771-9. PubMed ID: 8781434
    [Abstract] [Full Text] [Related]

  • 6. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S, Wlodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C.
    Am J Pathol; 1997 Aug 01; 151(2):343-51. PubMed ID: 9250148
    [Abstract] [Full Text] [Related]

  • 7. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
    Drexler HG, Gignac SM, von Wasielewski R, Werner M, Dirks WG.
    Leukemia; 2000 Sep 01; 14(9):1533-59. PubMed ID: 10994999
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of CD56 expression for ALK-positive and ALK-negative anaplastic large-cell lymphoma of T/null cell phenotype.
    Suzuki R, Kagami Y, Takeuchi K, Kami M, Okamoto M, Ichinohasama R, Mori N, Kojima M, Yoshino T, Yamabe H, Shiota M, Mori S, Ogura M, Hamajima N, Seto M, Suchi T, Morishima Y, Nakamura S.
    Blood; 2000 Nov 01; 96(9):2993-3000. PubMed ID: 11049976
    [Abstract] [Full Text] [Related]

  • 9. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y, Suzuki R, Taji H, Yatabe Y, Takeuchi T, Maeda S, Kondo E, Kojima M, Motoori T, Mizoguchi Y, Okamoto M, Ohnishi K, Yamabe H, Seto M, Ogura M, Koshikawa T, Takahashi T, Kurita S, Morishima Y, Suchi T, Nakamura S.
    Am J Surg Pathol; 1999 Oct 01; 23(10):1184-200. PubMed ID: 10524519
    [Abstract] [Full Text] [Related]

  • 10. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaining.
    Lamant L, Meggetto F, al Saati T, Brugières L, de Paillerets BB, Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Rigal F, Schlaifer D, Shiuta M, Mori S, Delsol G.
    Blood; 1996 Jan 01; 87(1):284-91. PubMed ID: 8547653
    [Abstract] [Full Text] [Related]

  • 11. ALK-negative anaplastic large-cell lymphoma demonstrates similar poor prognosis to peripheral T-cell lymphoma, unspecified.
    ten Berge RL, de Bruin PC, Oudejans JJ, Ossenkoppele GJ, van der Valk P, Meijer CJ.
    Histopathology; 2003 Nov 01; 43(5):462-9. PubMed ID: 14636272
    [Abstract] [Full Text] [Related]

  • 12. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT, Ponzoni M, Merson A, Goldstein M, Scarpa A, Chilosi M, Menestrina F, Pittaluga S, de Wolf-Peeters C, Shiota M, Mori S, Frizzera G, Inghirami G.
    Blood; 1996 Feb 01; 87(3):1081-8. PubMed ID: 8562933
    [Abstract] [Full Text] [Related]

  • 13. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
    Nakamura S, Shiota M, Nakagawa A, Yatabe Y, Kojima M, Motoori T, Suzuki R, Kagami Y, Ogura M, Morishima Y, Mizoguchi Y, Okamoto M, Seto M, Koshikawa T, Mori S, Suchi T.
    Am J Surg Pathol; 1997 Dec 01; 21(12):1420-32. PubMed ID: 9414185
    [Abstract] [Full Text] [Related]

  • 14. Genomic DNA amplification and the detection of t(2;5)(p23;q35) in lymphoid neoplasms.
    Sarris AH, Luthra R, Cabanillas F, Morris SW, Pugh WC.
    Leuk Lymphoma; 1998 May 01; 29(5-6):507-14. PubMed ID: 9643564
    [Abstract] [Full Text] [Related]

  • 15. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
    ten Berge RL, Oudejans JJ, Ossenkoppele GJ, Pulford K, Willemze R, Falini B, Chott A, Meijer CJ.
    J Clin Pathol; 2000 Jun 01; 53(6):445-50. PubMed ID: 10911802
    [Abstract] [Full Text] [Related]

  • 16. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1.
    Pulford K, Lamant L, Morris SW, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY.
    Blood; 1997 Feb 15; 89(4):1394-404. PubMed ID: 9028963
    [Abstract] [Full Text] [Related]

  • 17. Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions.
    Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC.
    Blood; 1995 Nov 01; 86(9):3517-21. PubMed ID: 7579458
    [Abstract] [Full Text] [Related]

  • 18. The t(2;5) in human lymphomas.
    Kadin ME, Morris SW.
    Leuk Lymphoma; 1998 Apr 01; 29(3-4):249-56. PubMed ID: 9684923
    [Abstract] [Full Text] [Related]

  • 19. Differential expression of BCL-2 family proteins in ALK-positive and ALK-negative anaplastic large cell lymphoma of T/null-cell lineage.
    Rassidakis GZ, Sarris AH, Herling M, Ford RJ, Cabanillas F, McDonnell TJ, Medeiros LJ.
    Am J Pathol; 2001 Aug 01; 159(2):527-35. PubMed ID: 11485911
    [Abstract] [Full Text] [Related]

  • 20. ALK+ lymphoma: clinico-pathological findings and outcome.
    Falini B, Pileri S, Zinzani PL, Carbone A, Zagonel V, Wolf-Peeters C, Verhoef G, Menestrina F, Todeschini G, Paulli M, Lazzarino M, Giardini R, Aiello A, Foss HD, Araujo I, Fizzotti M, Pelicci PG, Flenghi L, Martelli MF, Santucci A.
    Blood; 1999 Apr 15; 93(8):2697-706. PubMed ID: 10194450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.